Seres Therapeutics Inc (NASDAQ:MCRB) currently has a daily average trading volume of 3.88M but it saw 1492677 shares traded in last market. With a market cap of 128.84M USD, the company’s current market price of $0.76 came falling about -3.26 while comparing to the previous closing price of $0.78. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.05 and as low as $0.54. In the recent trading on the day, stock has struck highest price mark of $0.7511 while lowest mark touched by it was $0.8005.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which resumed the stock as “Outperform” in its note to investors issued on June 26, 2023, recommending a price target of $12 for it. Goldman issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $24 and $7.
Over the week, MCRB’s stock price is moving -10.16% down while it is -31.80% when we observe its performance for the past one month. Year-to-date it is -45.93% down and over the past year, the stock is showing a downside performance of -50.52%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.37 beat the consensus estimate of -0.5 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of -0.24 while estimate for next year EPS is -0.94.
Currently, Seres Therapeutics Inc’s total number of outstanding shares is 135.04M. Company’s return on investment (ROI) stands at -139.32% and return on equity (ROE) at -538.57%. Stock’s beta reads 2.02. Stock has a price to sale or P/S ratio amounts to 348.22. Its return on asset (ROA) is -44.53% on average.
